Nontypeable Haemophilus influenzae (NTHi) are obligate parasites of the human upper respiratory tract that can exist as commensals or pathogens. Toxin-antitoxin (TA) loci are highly conserved gene pairs that encode both a toxin and antitoxin moiety.
INTRODUCTION
Nontypeable H. influenzae (NTHi) are small facultative Gram-negative pleomorphic coccobacilli that lack the genes to produce and assemble a polysaccharide capsule. NTHi are fastidious and require exogenous heme or protoporphyrin IX for aerobic growth as well as nicotinamide adenine dinucleotide (NAD) when cultured in the absence of human cells. As these organisms are obligate parasites on the mucous membranes of humans, there are no natural animal or environmental reservoirs.
H. influenzae are acquired in the nasopharynx shortly after birth and can exist as commensals or pathogens. Mucosal infections associated with NTHi include otitis media, conjunctivitis, sinusitis, epiglottitis and pneumonia (24) . NTHi is the leading cause of chronic bronchitis in adults, and is implicated in exacerbations of chronic obstructive pulmonary disease (COPD) (25) . Otitis media (OM) is the second most prevalent infection of young children worldwide. Hearing loss is the most common sequelae of OM, with behavioral, educational and language development delays being additional consequences of early onset otitis media with effusion. The estimated annual direct medical costs from OM range from $1.96 billion to $4.1 billion (33) .
Invasive NTHi infections include bacteremia and meningitis; traversal of epithelial or endothelial cells by the bacterium is required for these infections to occur. Prior to 1985, most invasive H. influenzae infections were due to encapsulated type b strains.
During that year, a polysaccharide conjugate vaccine against the type b polyribosylribitol phosphate capsule (Hib) was licensed and distributed in the United States. Disease caused by type b has been drastically curtailed since. However, the vaccine is not protective against NTHi, since these strains lack the capsular antigen.
Efforts to identify NTHi vaccine candidates are ongoing and include strategies using immunogenic surface-exposed loops of the P2 and P4 outer membrane proteins (15, 27) , the C-terminal fragment of the Hap autotransporter (22) , conjugate vaccines with outer membrane protein P6 as a carrier (37) , and oral vaccines composed of killed bacterial extracts (2) .
First identified in pathogenic strains of the Gram-negative, strict anaerobe Dichelobacter nodosus, virulence-associated protein (vap ) genes were found on a novel area of the chromosome that hybridized to nearly all virulent strains tested, but to only 23% of the avirulent strains studied (16) . The chromosomes of the NTHi strains Rd KW20 (11) , R2866 (28) and 86-028NP (14) contain homologues of vapA, vapB, vapC, and vapD, with one gene pair, vapBC, in duplicate.
The genetic organization of the NTHi vap genes is similar to toxin-antitoxin (TA) loci. Characteristic features of TA loci are that the toxin/antitoxin gene pair is an operon, consisting of an upstream antitoxin and a downstream toxin gene. The antitoxins prevent the effects of the toxins by forming tight complexes with them. The antitoxins are more labile than the toxins, and under conditions of stress are quickly degraded by cellular proteases. This allows their cognate toxins to become active (13) .
Seven TA gene families have been identified to date: relBE, parDE, higBA, vapBC, mazEF, phd/doc, and ccdAB (30) . All except the vapBC and mazEF loci were originally discovered on plasmids. Although TA loci were first thought to be merely plasmid addiction modules, the discovery that these gene pairs were conserved in the chromosomes of numerous diverse prokaryotes (Gram-negative, Gram-positive as well as the Archaea) did not support that hypothesis and led to the notion that TA loci are important in the regulation of certain cellular functions. In a database mining effort that included 126 completely sequenced prokaryotic genomes, 671 TA loci were identified (30) . Of these, 285 (42%) were vapBC homologues.
The vapBC alleles in NTHi have been shown to be expressed by proteomic studies (12, 17, 19) . As NTHi carry two chromosomal vapBC operons (HI0321/HI0322 and HI0948/HI0947), for clarity we shall refer to these as vapBC-1 and vapBC-2. Here we describe the functional characteristics of NTHi vapBC-1 (HI0321/HI0322).
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains and plasmids used in these studies are listed in Table 1 . E. coli strains were grown in LB broth or agar ± 30 micrograms/ml kanamycin or 100 micrograms/ml ampicillin, as required.
Induction of protein expression was with the addition of 1 mM IPTG for 2 hours. For the protein-protein interaction studies, SU101 carrying pDD687 was grown overnight in LB broth containing 1 mM IPTG, then diluted and grown to log phase in LB + 1 mM IPTG prior to beta-galactosidase activity assays. H. influenzae strains were grown in BHI broth or agar supplemented with 10 micrograms/ml heme-histidine and beta-NAD (sBHI). All were cultured at 37ºC in room air.
Cloning of vapB-1, vapC-1 and cat.
Each vap gene was cloned into the expression vectors pTrcHisA and pET24b as a single copy. As well, both were cloned in a tandem fashion in pET24b. The cat gene was cloned into pET24b. All primers used in this study were synthesized by Integrated DNA Technologies (Coralville, IA).
pTrcHisA cloning: vapB-1 was amplified by PCR using the primers 321 forward 5'-GAGAGAATTCATATGCTTACTAAAGTG-3' and 321 reverse 5'-AACAAAGCTTTCATAAATTTTCTCGC-3'. The primers included the engineered restriction sites EcoRI and HindIII (underlined) respectively, and resulted in pDD676.
Similarly, vapC-1 was amplified using the primers 322 forward 5'-GCGAGAATTCTTATGATTTATATGTTAG-3' and 322 reverse 5'-TCAGAAGCTTCTATTTTGTCCAATCTTGCC-3' with the same engineered sites, and resulted in pDD677. Both were ligated into EcoRI/HindIII-cut pTrcHisA and expressed in E. coli strain DH5α. pET24b cloning: vapB-1 was amplified using the primers 2866B Homodimerization assays. For these assays, vapB-1 was fused to the LexA DNA-binding domain (DBD) in the vector pSR658 (7) , resulting in pDD687, and expressed in the reporter strain SU101. This strain has a chromosomal construct that consists of a lacZ reporter gene controlled by the strong sulA promoter, which contains a LexA operator sequence. When there is no fusion to the LexA DBD, the strain constitutively expresses a high level of beta-galactosidase. However, if a protein fused to the LexA DBD in pSR658 can homodimerize, this results in a competent LexA dimer that can bind to the LexA operator and repress transcription of lacZ. Expression of the LexA fusion in pSR658 is induced by IPTG, and since beta-galactosidase is a very longlived enzyme, the reporter strain is routinely grown overnight in the inducer, so that any enzyme that was transcribed prior to induction of the LexA chimera has the opportunity to degrade. This results in a more reliable and specific measurement of homodimerization.
Following overnight incubation in LB broth with 1 mM IPTG, the reporter strain carrying pDD687 was diluted and grown to log phase in LB broth with 1 mM IPTG. The amount of homodimerization was quantitated by beta-galactosidase activity assays and compared to the reporter strain carrying pSR658 (no fusion).
Protein purification and antibodies. Proteins were purified from induced cultures using the MagneHis protein purification system (Promega #V8500) according to the manufacturer's instructions. Briefly, E. coli strains DH5alpha or BL21(DE3) carrying the various fusions were grown to log phase in LB broth with appropriate antibiotics and induced for 2 hours with 1 mM IPTG. The cells were pelleted, frozen at -80ºC, and subjected to 3 freeze-thaw cycles prior to being processed using the MagneHis kit protocol for native purification. Protein concentration was quantitated using the micro BCA protein assay (Pierce #23235). Aliquots of purified protein were frozen at -80ºC and thawed when needed, after which the thawed aliquot was held at 4ºC until used in assays.
Antibodies used to probe immunoblots were monoclonal Anti-Xpress-HRP (Invitrogen #R911-25) for pTrcHis fusions and monoclonal Anti-His (C-term)-HRP (Invitrogen #R931-25) for pET24b fusions. Immunoblots were developed using the SuperSignal West Pico substrate (Pierce #34080). SDS-polyacrylamide gels were stained with Coomassie Blue and destained with 10% acetic acid.
Total RNA isolation. Cultures of E. coli K-12 (ATCC #10798) and H. influenzae strains R2866 and 86-028NP were grown to log phase and processed using the Promega SV total RNA isolation kit (Promega #Z3101) according to the manufacturer's instructions. The purified total RNA was then subjected to spectrophotometry at 260 and 280 nm to determine its purity and concentration. Aliquots were frozen at -80ºC, and each was thawed only once before use in reverse-transcriptase PCR or ribonuclease activity assays.
Reverse-transcriptase PCR. First-strand cDNA synthesis was performed using AMV reverse transcriptase according to the manufacturer's instructions (Promega #M5101). Briefly, aliquots of purified total RNA corresponding to 250 nanograms from NTHi strains R2866 or 86-028NP were incubated at 70ºC for 5 minutes with the primer RT BC1 reverse 5'-CAATGCGTGACAAGCGATCC-3', which anneals to vapC-1. The mixtures were chilled on ice, centrifuged to collect, then incubated at 37ºC for one hour with 1 microliter (10 Units) AMV reverse transcriptase, 4 microliters 5X AMV buffer, 1 microliter of 10 mM dNTPs, and nuclease-free water to a final volume of 20 microliters.
Control reactions were identical but included no AMV reverse transcriptase. Following this incubation, a 2.5 microliter aliquot of each cDNA synthesis reaction was used as the template for conventional PCR with the primers RT BC1 forward 5'-CAAAAGTGGTAACAGCCAAGC-3', which anneals to vapB-1. and RT BC1 reverse 5'-CAATGCGTGACAAGCGATCC-3', which anneals to vapC-1.
Promoter::reporter gene fusion construction. A 340 base pair sequence located upstream of the vapBC-1 allele in strains R2866 and 86-028NP that included the first seven amino acids of vapB-1 was amplified by PCR using the primers BC 1403 forward 5'-ACTAGAATTCATCATTTACTCATTGACTTGC-3' and BC 1403 reverse 5'-
GTTAGGATCCTGAAACACTTTAGTAAGC-3', which included engineered EcoRI and
BamHI sites (underlined), respectively. These fragments were then ligated in frame with a promoterless lacZ reporter gene in the vector pMC1403 (5), creating pDD693 (R2866 vapBC-1 promoter fusion) and pDD694 (86-028NP vapBC-1 promoter fusion).
Beta-galactosidase activity assays were performed in triplicate during lag phase and early, mid, and late logarithmic phases. 
Ribonuclease activity assays. Aliquots of purified

RESULTS
Both NTHi strains R2866 and 86-028NP express vapBC-1. The genomes of the NTHi invasive blood isolate R2866 (28) , and pediatric otitis media isolate 86-028NP (14) have been completely sequenced, and the vapBC-1 allele is identical at the DNA level in both strains. To determine if vapBC-1 was expressed, total RNA from each strain grown to log-phase in sBHI was subjected to reverse-transcriptase PCR using a forward primer that annealed to vapB-1, and a reverse primer located in vapC-1. The resulting 535 base pair product in the reactions that included AMV reverse transcriptase, but not in the control reactions without reverse transcriptase, showed that both R2866 and 86-028NP express vapBC-1 and transcribe the gene pair as an operon (Figure 1, lanes 2 and 5, respectively).
Expression of vapBC-1 is inversely related to culture density. Fragments
that included the predicted promoter and transcription start sites of vapBC-1 in R2866 and 86-028NP identified by a neural network program (available at http://searchlauncher.bcm.tmc.edu/seq-search/gene-search.html) which also included the first seven amino acids of vapB-1 were fused in frame with a promoterless lacZ reporter gene in pMC1403 and transferred to E. coli strain DH5alpha. Since there was a single nucleotide polymorphism between strains R2866 and 86-028NP at a site located 10 bases into the predicted transcript, with five additional polymorphisms scattered upstream, we fused both promoter regions to the reporter gene and analyzed the activity of each at culture densities corresponding to lag phase and early, mid, and late logarithmic phases ( Figure 2 ). We found that there was relatively greater betagalactosidase activity in the strain carrying the R2866 promoter fusion during lag phase than in the strain carrying the 86-028NP promoter fusion, an average of 241 ±15 versus 171 ±10 Miller units (Figure 2A and 2B, respectively). In both cases, the activity decreased with increasing culture density and approached identical levels during late growth phase (95 ±2 versus 100 ±15 Miller units, respectively). The negative control, pMC1403 with no promoter fusion, did not deliver detectable beta-galactosidase activity at any point during the growth cycle (data not shown).
Purified NTHi VapB-1 forms multimers in vitro.
VapB-1 is the putative antitoxin protein of the vapBC-1 operon. We used the pTrcHisA vector (Invitrogen, Carlsbad, CA) to clone, overexpress, and natively purify VapB-1. This vector includes an N-terminal polyhistidine fusion that allows affinity purification using paramagnetic nickel beads, as well as an epitope tag (Xpress) for which a monoclonal HRP-linked antibody is commercially available. Figure 3A Figure 6A ). The vector pET24b is highly regulated, since the T7 phage promoter that controls transcription requires prior induction of its cognate RNA polymerase. Thus, when the T7 RNA polymerase is induced by IPTG in E. coli strain BL21(DE3), both vapB-1 and vapC-1 are transcribed, but only vapC-1 is polyhistidinetagged. This strategy ensured that each full-length VapC-1 toxin was paired with at least one full-length VapB-1 antitoxin, and resulted in the restoration of normal growth in the expression strain (data not shown). In this system, the apparent molecular mass of pET::VapB-1 is 10.5 kDa, and pET::VapC-1 is 16.6 kDa. Figure 6B Figure   6C ). The fact that we were able to successfully purify a native His-tagged VapC-1 toxin from this tandem cloning is evidence that the presence of VapB-1 is necessary to prevent the VapC-1-induced growth inhibition of the expression strain.
The VapC-1 toxin is a ribonuclease that acts on free RNA in vitro. The
VapC-1 toxin contains a motif known as a PilT N-terminus (PIN) domain that consists of about 100 amino acids with two nearly invariant aspartate residues. These residues have been shown to be essential for metal ion coordination in other PIN-domain containing proteins that are ribonucleases (10) . The PIN domain protein family displays similarity to the nuclease domains of Taq polymerase, T4 RNase H, and the 5'-3' flap endonucleases (3) . Accordingly, we performed ribonuclease activity assays with purified VapC-1 to determine whether it was enzymatically active on purified total RNA in vitro. As a control to ensure that any activity observed with VapC-1 was specific, and not due to a ribonuclease that may have co-purified with the protein, the chloramphenicol acetyltransferase (cat) gene from pACYC184 was fused to the pET24b vector, overexpressed in the E. coli strain BL21(DE3), and natively purified in an identical fashion to VapC-1. The Cat protein is a known homotrimer that displays no ribonuclease activity. Figure 7A shows that the VapC-1 toxin can efficiently degrade both E. coli K-12 and H. influenzae strain 86-028NP total RNA in a concentration-dependent manner in vitro. Note the natural 23S rRNA cleavage pattern of strain 86-028NP. That Haemophilus species display 23S fragmentation heterogeneity is a previously reported phenomenon (34) . Figure 7B shows that the VapC-1 ribonuclease activity is specific, as incubating strain 86-028NP total RNA substrate with the same amount of the Cat protein, which had been cloned, overexpressed, and purified in an identical fashion as VapC-1, results in no significant degradation as quantitated by densitometry. For these assays, we cloned VapB-1 into the pET24b vector as a single gene and purified it in an identical manner as the VapC-1 protein, so that both proteins would be expressed from the same vector in the same expression strain. Figure 8 shows that
VapB-1 has no intrinsic ribonuclease activity by itself, and that preincubation with a 4:1 ratio of VapB-1 to VapC-1 abrogates the ribonuclease activity of VapC-1. A 2:1 ratio of VapB-1 to VapC-1 partially inhibits the ribonuclease activity of VapC-1. For these assays, we used both E. coli K-12 total RNA and NTHi strain R2866 total RNA as substrates. Note that strain R2866 displays a different natural 23S ribosomal RNA fragmentation pattern than that of strain 86-028NP.
DISCUSSION
E. coli expresses the chromosomal TA loci relBE and mazEF. The RelE toxin has been identified as a global inhibitor of translation, and is induced under starvation conditions (6) . RelE is a sequence-specific RNase, cleaving mRNA in the A site of the ribosome, but it is unable to degrade free RNA (32) . The MazE antitoxin is degraded by the cellular protease ClpPA (1), and this results in the activation of the toxin MazF, which cleaves single-stranded RNA independent of ribosomes. This makes MazF functionally distinct from the RelE toxin (39) . In this study, we show that NTHi VapC-1 displays MazF-like activity; that is, the toxin is active on free RNA in vitro. Interestingly, H. influenzae does not contain a mazEF homologue, whereas E. coli, on the other hand, does not contain any vapBC homologues. Further support for this apparent trend toward mutual exclusivity comes from a group that surveyed 23 separate genomes and found that 20 contained either a mazEF locus or a vapBC locus, but not both (40) .
Although most organisms carry various TA loci in their genomes, the reason why these genes are so highly conserved as well as what their exact purpose might be remains controversial. Some investigators posit that free-living organisms carry more TA loci in their genomes than host-adapted organisms do because the former encounters harsh environmental conditions, whereas adaptation to a host organism may require only a few TA operons to serve a similar function (30) . One caveat to this view is that the prevalence of TA modules in a genome may not always correlate with their expression or activity. In E. coli, it was originally thought that the toxins RelE and MazF killed the cells, since investigators observed a dramatic loss of colony formation when these toxins were released from their antitoxins (13) . It was later shown, however, that these toxins did not actually kill the cells, but instead contributed to a reversible bacteriostatic state in which the cells were unable to form a colony -they were viable but nonreplicative. Expression of the cognate antitoxins rescued these cells and allowed colony formation (6, 31) . It has been suggested that induction of a reversible viable but nonreplicative state is important for cells to survive in a competitive or harsh environment, in nature or inside a host (24) , and there is evidence that H.
influenzae enters a bacteriostatic state in the middle ear during the course of otitis media with effusion (26) . In addition to enhancing survival under suboptimal conditions, a strategy of reversible growth arrest could provide a mechanism for non-specific antibiotic resistance (nongrowing cells are not susceptible to the cidal action of most antibiotics) as well as decrease each cell's metabolic burden and energy requirements.
A recent competing hypothesis put forward is that the mazEF TA locus can induce a programmed cell death (PCD) cycle that mimics the PCD observed in multicellular organisms (8) . This line of reasoning is supported by the observation that, while the MazE antitoxin can rescue MazF toxin overexpression in the short term, there seems to be a "point of no return" after which no amount of MazE antitoxin will allow the culture to recover. However, there are three points to consider in this debate: first, the results of these in vitro PCD experiments seem to show that, even after 24 hours, there is a very small (1-5%) portion of the culture that does survive (18) . This could be enough to maintain a "founder" population that could resume replication after conditions improved, particularly in vivo (20) . Second, a confounding element of life on human mucosal surfaces is that many organisms, including H. influenzae, form biofilms in this environment, and growth in biofilms has been shown to modulate the metabolic characteristics of a number of organisms as compared to those grown in planktonic culture (21, 36) . Further, even within an in vitro planktonic culture, there is an observable difference between the amount of bacterial cells that persist following antibiotic treatment, which depends upon whether the culture is in logarithmic or stationary phase at the time of antibiotic addition (35) . Third, the aforementioned experiments were performed with one type of TA locus (mazEF) and the results observed regarding this particular module might not be generally applicable to the TA superfamily as a whole. Indeed, a recent study of one of the two higBA TA alleles carried in the superintegron of ChrII of V. cholerae suggested that the expression of the HigB toxin at endogenous levels for several hours was not bactericidal, but the function of the toxin was not elucidated (4) . Therefore, at this point, it may be premature to accept either view as being entirely correct.
Our results indicate that the vapBC-1 allele in two clinical isolates of NTHi is expressed as a functional TA locus with VapB-1 as the antitoxin and VapC-1 as the ribonuclease toxin. The gene pair is transcribed as an operon in both NTHi strains and each promoter appears to be more active during lag phase, with expression displaying an inverse relation to culture density. VapC-1 is active on free RNA purified from two different genera in vitro, but does not display general nuclease activity, as it did not degrade double-or single-stranded DNA under the same conditions. The homodimerization observed with VapB-1, coupled with the ratio of antitoxin to toxin protein required to abrogate VapC-1 activity, suggests that the nontoxic VapBC-1 complex consists of VapB-1 multimers interacting with VapC-1 moieties in vivo. This is reminiscent of the MazEF complex, which has been shown to form a heterohexamer (38) . The degradation of the labile VapB-1 antitoxin under stress would allow the stable VapC-1 toxin to actively inhibit protein synthesis by cleaving mRNA. The entry of NTHi into a bacteriostatic state induced by suboptimal conditions could be involved in mucosal infections that recur following antibiotic treatment, such as otitis media and bronchitis. On the other hand, even if most of the infecting population were killed by toxin induction, a small surviving segment could be responsible for the re-seeding of tissues observed in chronic disease.
Interestingly, TA loci are conserved (often in multiple copies) in the genomes of many organisms that can cause persistent infections and/or persist in the environment: M. tuberculosis, H. pylori, C. burnetii, L. interrogans, V. cholerae, S. enterica serovar typhi and typhimurium, as well as H. influenzae (9, 23, 29, 30) . It is intriguing that a human-adapted organism such as H. influenzae would maintain two vapBC alleles on its very small (~2.0 Mb) chromosome, and suggests that both may be important for its lifestyle. Further studies are planned to investigate the in vivo function and synergy of the NTHi vap alleles. the chimeras can bind to the LexA operator sequence, repressing transcription of the reporter gene (black bar). This level of repression indicates strong VapB-1 homointeraction. influenzae strain R2866 total RNA was used. Note the natural 23S fragmentation pattern, which differs from that of strain 86-028NP. 23S 16S E. coli K-12 RNA NTHi R2866 RNA Figure 8 
